Purpose: This study aimed to investigate the regulatory effect of long non-coding RNA (lncRNA) NBAT-1 (neuroblastoma associated transcript 1) on the development and prognosis of gastric cancer (GC), and its underlying mechanism.
Methods: NBAT-1 expression in GC tissues, paracancerous tissues and normal gastric tissues was detected by quantitative real-time polymerase chain reaction (qRT-PCR). We also detected NBAT-1 expression in GC cell lines. Correlation between NBAT-1 expression and TNM stage was analyzed. Overexpression plasmid of NBAT-1 was transfected into SGC-7901 and MGC-823 cells, followed by detection of proliferation and cell cycle by CCK-8 (cell counting kit-8) assay and flow cytometry. NBAT-1 localization in GC cells was accessed by chromatin fractionation. Finally, PTEN expression in GC cells overexpressing NBAT-1 was determined by Western blot analysis.
Results: NBAT-1 and PTEN were lowly expressed in GC tissues compared with paracancerous tissues and normal gastric tissues. GC patients with stage Ⅲ-Ⅳ presented lower expression of NBAT-1 than those with stage Ⅰ-Ⅱ. Besides, lower expression of NBAT-1 was found in GC patients with N2-N3 compared with those with N0-N1. NBAT-1 expression was not correlated with TNM stage and distant metastasis in GC patients. Upregulation of NBAT-1 in GC cells inhibited proliferation and arrested cell cycle. Chromatin fractionation results indicated that NBAT-1 was mainly localized in the cytoplasm of SGC-7901 and MGC-823 cells. NBAT-1 overexpression remarkably upregulated PTEN expression in GC cells.
Conclusions: Low expression of NBAT-1 promotes GC development by downregulating PTEN expression.
Download full-text PDF |
Source |
---|
Cell Signal
February 2025
Amrita Research Center, Amrita Vishwa Vidyapeetham, Amrita Hospital, Mata Amritanandamayi Marg, Faridabad 121002, India. Electronic address:
Previously considered junk or non-functional, long non-coding RNAs (lncRNAs) have emerged over the past few decades as pivotal components in both physiological and pathological processes, including cancer. Neuroblastoma-associated transcript-1 (NBAT-1) was initially discovered a decade ago as a risk-associated tumor suppressor lncRNA in neuroblastoma (NB). Subsequent studies have consistently demonstrated that NBAT-1 serves as a dedicated tumor suppressor in many cancers.
View Article and Find Full Text PDFBMC Cancer
January 2024
Department of Oncology, Affiliated Tumour Hospital of Nantong University, Nantong, Jiangsu Province, People's Republic of China.
Purpose: There is an aberrant expression of NBAT-1 in various human cancers, which was proven to limit the proliferation, invasion, and metastasis of tumour cells via multiple approaches. Most existing research focuses on sample size and discrete outcomes. Thus, a quantitative meta-analysis was performed to elucidate the prognostic value of lncRNA NBAT-1 expression in cancer patients.
View Article and Find Full Text PDFMol Carcinog
March 2023
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Background: Hepatocellular Carcinoma (HCC) is a universal health problem responsible for 8.2% of all cancer deaths. Numerous risk factors were documented to be contributed to HCC development with viral hepatitis C ranking as the major predisposing factor in Egypt.
View Article and Find Full Text PDFJ Healthc Eng
May 2022
Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Background: Increasing evidence shows that dysfunction of noncoding RNAs is implicated in cancer. Neuroblastoma associated transcript 1 (NBAT-1) has been identified as a tumor suppressive lncRNA that is aberrantly expressed in cancers. However, the function and the underlying mechanisms of the NBAT-1 in colorectal carcinoma (CRC) remain unknown.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!